2006 Jul;91(7):610-1.

Author information

1
Department of Neurology, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA. tcrawfo@jhmi.edu

Abstract

Ataxia telangiectasia is a rare, multiorgan neurodegenerative disorder with enhanced vulnerability to cancer and infection. Median survival in two large cohorts of patients with this disease, one prospective and one retrospective, is 25 and 19 years, with a wide range. Life expectancy does not correlate well with severity of neurological impairment.

PMID:
 
16790721
 
PMCID:
 
PMC2082822
 
DOI:
 
10.1136/adc.2006.094268
[Indexed for MEDLINE] 
Free PMC Article